Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 51224-007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 51224-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tagi Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Metformin 01)

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Each tablet contains 500 mg of metformin hydrochloride. Please see the enclosed package insert for dosage information. The tablets should be stored in a cool, dry place between 20 to 25°C (68" to 77°F), with excursions permitted from 15° to 30°C (59° to 86°F). The medication should be dispensed in light-resistant containers. Manufactured by CSPC Ouyi Pharmaceutical Co. Ltd. for TAGI Pharma, Inc. This is a prescription-only medication, and the pharmacist should provide the patient information separately to each patient. NDC number: 51224-007-70. Revision date: September 2018.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.